A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of lenacapavir – Gilead’s twice-yearly ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Lenacapavir is an injectable medicine that only needs to be taken twice a year, making it easier to use than daily HIV pills.
B.C. medical breakthrough led to a global decline in HIV cases. Now a patient and the doctor who pioneered the treatment are both raising concerns that recent international funding cuts may threaten ...
10d
Injectable PrEP approved in Northern Ireland following NHS milestone in monumental HIV breakthrough
"Eligible patients in Northern Ireland may receive this treatment," says the Department of Health The post Injectable PrEP ...
The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback